Gad Thomas - Insider Non-Derivative Transactions at Y-mAbs Therapeutics, Inc. (YMAB) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Sep 19, 2024, Gad Thomas's relationship to Y-mAbs Therapeutics, Inc. (YMAB) is Director,Officer (CHIEF BUSINESS OFFICER), and currently has 181,531 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other YMAB insiders.

Data Source: SEC.
Gad Thomas - Insider Non-Derivative Transactions of YMAB Common Stock
Gad Thomas - Insider Non-Derivative Transactions at YMAB
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Sep 20, 2024 M -- (Common Stock) 22831 4.38 181531
Sep 17, 2024 Sell -- (Common Stock) 30000 12.97 67681
Sep 14, 2024 Sell -- (Common Stock) 65000 13.47 97681
Jun 12, 2024 Sell -- (Common Stock) 35000 12 162681
Jun 11, 2024 Sell -- (Common Stock) 35000 12.03 197681
May 24, 2024 Sell -- (Common Stock) 7351 13 232681
May 22, 2024 Sell -- (Common Stock) 25000 12 240032
Mar 6, 2024 Sell -- (Common Stock) 3900 16.44 158700
Jan 19, 2024 Acquisition -- (Common Stock) 22100 0 162600
Dec 22, 2023 M -- (Common Stock) 50000 2 140500
Dec 16, 2023 Sell -- (Common Stock) 50000 6.61 265032
Dec 15, 2023 Sell -- (Common Stock) 50000 6.83 315032
Dec 14, 2023 Sell -- (Common Stock) 50000 6.58 365032
Nov 22, 2023 Sell -- (Common Stock) 75000 5.31 415032
Nov 21, 2023 Sell -- (Common Stock) 75000 5.3 490032
Jan 18, 2023 Acquisition -- (Common Stock) 40500 0 90500